Technical Analysis for ORPH - Open Orphan plc

Grade Last Price % Change Price Change
F 18.8 3.01% 0.55
ORPH closed down 0.05 percent on Wednesday, December 1, 2021, on 2.89 times normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical ORPH trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 3.01%
Lizard Bullish Bullish Day Trade Setup 3.01%
Doji - Bullish? Reversal 3.01%
Lower Bollinger Band Walk Weakness 3.01%
New 52 Week Low Weakness 3.01%
BB Squeeze Ended Range Expansion 3.01%
Below Lower BB Weakness 3.01%
Down 3 Days in a Row Weakness 3.01%
Down 4 Days in a Row Weakness 3.01%
Lower Bollinger Band Touch Weakness 3.01%
Older End-of-Day Signals for ORPH ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Lizard Bullish Entry about 1 hour ago
Rose Above Previous Day's High about 1 hour ago
Up 3% about 1 hour ago
Rose Above Lower Bollinger Band about 1 hour ago
Up 2% about 1 hour ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Open Orphan plc operates as a clinical research organization pharmaceutical services company with a focus on virology, vaccine studies, and orphan drugs in the United Kingdom, Ireland, France, the Netherlands, Germany, and Singapore. It operates a virtual rep, a pharmaceutical commercialization platform for rare/orphan disease space; and develops Genomic Health Data platform, a collection of infectious disease progression data. The company also provides consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations. In addition, it offers hVIVO COVID Clear Test, an antibody test for employers in the United Kingdom and Ireland. The company is headquartered in London, the United Kingdom.
Classification

Keywords: Health Biotechnology Life Sciences Clinical Trial Pharmaceutical Industry Health Sciences Drug Discovery Clinical Research Infectious Disease Vaccine Pharmaceuticals Policy Design Of Experiments Food And Drug Administration Clinical Trial Services

Is ORPH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 48.0
52 Week Low 16.8601
Average Volume 1,584,727
200-Day Moving Average 28.27
50-Day Moving Average 20.45
20-Day Moving Average 19.60
10-Day Moving Average 19.38
Average True Range 1.25
ADX 12.15
+DI 14.10
-DI 24.20
Chandelier Exit (Long, 3 ATRs) 18.04
Chandelier Exit (Short, 3 ATRs) 20.61
Upper Bollinger Bands 20.85
Lower Bollinger Band 18.35
Percent B (%b) -0.04
BandWidth 12.73
MACD Line -0.53
MACD Signal Line -0.44
MACD Histogram -0.095
Fundamentals Value
Market Cap 122.17 Million
Num Shares 669 Million
EPS
Price-to-Sales 12.40
Price-to-Book 9.22
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 20.71
Resistance 3 (R3) 20.52 19.51 20.30
Resistance 2 (R2) 19.51 18.88 19.60 20.16
Resistance 1 (R1) 18.88 18.50 19.19 19.07 20.03
Pivot Point 17.87 17.87 18.03 17.97 17.87
Support 1 (S1) 17.24 17.24 17.56 17.43 16.47
Support 2 (S2) 16.23 16.86 16.33 16.34
Support 3 (S3) 15.60 16.23 16.20
Support 4 (S4) 15.79